← Eichor
Study identifier: NCT06700304 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

CAN-PRIME: Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices

Condition: Tetraplegia/Tetraparesis · Quadriplegia · Quadriplegia/Tetraplegia  ·  Sponsor: Neuralink Corp

PhaseNA
Planned participants6
Who can joinAll sexes, 19 Years to no upper limit
Healthy volunteersNo

About this study

The CAN-PRIME Study is to test the safety and functionality of Neuralink's N1 Implant and R1 Robot in people who have difficulty moving their arms and legs (tetraparesis or tetraplegia). The N1 Implant is a small, wireless device placed in the skull. It connects to tiny threads inserted into the brain by the R1 Robot, which is a machine designed to carefully place these threads. This study will help researchers learn how well the implant and robot work and if they are safe for use.

This description comes directly from the study's public registry record.

Talk to the study team

Neuralink Clinical Team  ·  (877) 398-4465  ·  clinical-team-ct@neuralink.com

Always discuss trial participation with your own doctor first.

Locations (1)

University Health NetworkToronto, Ontario, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06700304